AzTrials
AzTrials

Chronic Anal FissureprofessorNCT04166175

High Dose Multiple Site Injection of Botox Versus Lateral Sphincterotomy in Chronic Analfissure

A study testing botox injection in intersphincteric space and lateral internal sphincterotomy in people with Chronic Anal Fissure, run by Zagazig University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

comparison between the effect of lateral sphincterotomy against high dose botox injection in chronic anal fissure the outcome was healing time, recurrence continence relapse pain pruritus Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Chronic Anal Fissure
What is being tested?
botox injection in intersphincteric space and lateral internal sphincterotomy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
1 siteEgypt
Study dates
1 Jun 2017to 30 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • patients suffering chronic anal fissure aged above 16 years old

Who cannot join

  • those with previous anal surgery,
  • complicated anal fissure,
  • unfit for surgery,
  • specific disease as Crohn's disease and ulcerative colitis,
  • malignancy,
  • anal fistula or abscess
  • those with systemic disease requiring treatment with calcium channel blockers and /or nitrates

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Zagazig Faculty of Medicine

    Zagazig, Sharqya, 44519

Other trials in Egypt

About this study

Official title: Treatment of Chronic Anal Fissure, Lateral Internal Sphincterotomy Versus Local Injection of High Dose Botulinum Toxin: A Randomized Clinical Trial

comparison between the effect of lateral sphincterotomy against high dose botox injection in chronic anal fissure the outcome was healing time, recurrence continence relapse pain pruritus

Read the detailed description

This randomized comparative clinical trial was carried out over 2 year in the period between January 2018 and December 2019 on total number of 96 patients suffering chronic anal fissure the participants were randomly allocated into two groups each 48 patients ; group (1) the botulinum ( Botox) group, they were subjected to 80 IU Botox injection as an intervention for treatment of chronic anal sphincter, and group 2 the sphincterotomy group, underwent internal sphincterotomy as a surgical intervention for treatment of chronic anal fissure.

The study was approved by the institutional review board and the local ethical committee of our university hospital The condition of the current study is chronic anal fissure defined as the presence of anterior or posterior chronic anal wound with skin tag at its lower end and hypertrophied anal papilla at its upper end with induration around its edges in patients complaining of anal pain, constipation, and/or fresh anal bleeding for at least two months.

Randomization was achieved using computer generated cards. Inclusion criteria; patients suffering chronic anal fissure aged above 16 years old Exclusion criteria; those with previous anal surgery, complicated anal fissure, unfit for surgery, specific disease as Crohn's disease and ulcerative colitis, malignancy, anal fistula or abscess those with systemic disease requiring treatment with calcium channel blockers and /or nitrates Patients of both groups were subjected to thorough history taking, clinical examination, digital rectal examination and anorectal manometry for diagnosis of chronic anal fissure and exclusion of any other anal condition and incontinence, patient signed an informed written consent, routine preoperative investigations performed as usual.

Interventions;

  1. Botulinum toxin (Botox) injection; was performed under general anesthesia in the lithotomy position, where 80 IU of Botox was injected in four positions each 20 IU namely in 5, 7, 11, and 1 O'clock positions in the intersphincteric space not deeper than the midpoint of the anal canal.
  2. Lateral internal sphincterotomy; was performed under general anesthesia where the lower part of the internal sphincter was cut by electrocautery on the left lateral position to an extent not beyond the proximal end of the fissure, the sentinel pile was also removed.

After the procedure patients were advised for bulking agents, stool softener, and sitz baths The follow up was carried out in the outpatient clinic by the attending surgeon (not a study participant) after 1 week then 1, 2, 3, 6, 9 and 12 months post-procedure.

The primary outcome of the current study is complete healing of the chronic anal fissure, recurrence in the follow up time, and development of incontinence, incontinence is described as in (the Cleveland Clinic Florida-Fecal Incontinence (CCF-FI) scoring system), which contains 5 questions on solid and liquid stool leakage, gas leakage, pad use, and lifestyle restriction. the secondary outcome is postoperative or post-injection pain measured by visual analogue scale (VAS) and the time taken for complete healing of fissure (defined as complete epithelialization of the fissure).

Demographic data, presentation data, follow up data including primary and secondary outcome all collected and analyzed properly using t test, chi square test, and Z test in SPSS program 22 version.

Being tested
botox injection in intersphincteric space, lateral internal sphincterotomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • botox injection in intersphincteric spaceProcedure or surgery

    injection of 80 IU of botox in the intersphincteric space in 5,7,11 and 1 O'clock position

  • lateral internal sphincterotomyProcedure or surgery

    lateral internal sphincterotomy under GA in lithotomy position

Study groups in NCT04166175
Study groupRoleWhat they receive
group 1 botox groupActive comparator48 patients subjected to 80 IU botox injection under GAin lithotomy position in the 5,7,11, and 1 O'clock positions
Receives: Procedure: botox injection in intersphincteric space
group 2 lateral sphincterotomy groupActive comparator48 patients subjected to lateral internal sphincterotomy under GAin lithotomy position
Receives: Procedure: lateral internal sphincterotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. complete healing of fissure

    complete epithelialization of the floor of the chronic anal wound achieved through clinical examination at follow up visits

    Measured: 2 months

  2. loss of anal continence

    inability to control stool or flatus measured by modified wexner score questionaire

    Measured: 1 week

  3. recurrence

    the anal fissure reformed again after complete healing measured by clinical examination

    Measured: 1 year

Secondary outcomes (2)
  1. time taken for complete healing

    time taken for complete epithelialization of the anal wound measured by clinical examination

    Measured: 1 year

  2. post operative pain

    pain in the postoperative time measured by visual analogue scale

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2019
  2. Study start1 Jun 2017
  3. Primary completion30 May 2019
  4. Study completion30 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
two groups of patients randomly allocated group1 the botox group received 80 IU botox injection and group 2 under went lateral internal sphincterotomy
Masking
Single blind
Who is masked
Participant
Enrolment
96 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04166175
Sponsor's protocol ID
anal sphincterotomy or botox
Acronym
professor
Status last verified
Nov 2019
First submitted
14 Nov 2019
Last updated
21 Nov 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing botox injection in intersphincteric space and lateral internal sphincterotomy in people with Chronic Anal Fissure, run by Zagazig University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

complete healing of fissure (time frame: 2 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in